Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
Abstract The current COVID-19 vaccines protect against severe disease, but are not effective in controlling replication of the Variants of Concern (VOCs). Here, we used the existing pre-clinical models of severe and moderate COVID-19 to evaluate the efficacy of a Spike-based DNA vaccine (pCTV-WS) fo...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-023-00616-y |